TMi is dedicated to saving sight for patients with Age Related Macular Degeneration.

Turning science into medicine is not a straight arrow that points one way. While great science drives great medicine, extensive knowledge from the clinic must strategically guide early research.

Driven by a passion for patient care, TMi has reverse-engineered its scientific program and developed a translational platform that extends from disease model, to biomarker, to a short pipeline of compounds that have pre-clinical efficacy with known clinical safety.

For more in Ophthalmology innovation visit:
[ Ссылка ]

свернуть